Howell F. Moffett, Ph.D.
Affiliations: | 2012 | Biology: Medical Sciences, Division of | Harvard University, Cambridge, MA, United States |
Area:
T Cell Biology and Cancer ImmunologyGoogle:
"Howell Moffett"Mean distance: 9.99 | S | N | B | C | P |
Parents
Sign in to add mentor| Kai W. Wucherpfennig | grad student | 2012 | Harvard | |
| (MicroRNAs in normal and malignant lymphocytes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moffett HF, Smith TT, Stephan MT. (2018) Abstract IA07: Genetic engineering of therapeutic T cells using synthetic nanoparticles Cancer Immunology Research. 6 |
| Moffett HF, Cartwright ANR, Kim HJ, et al. (2017) Erratum: The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection. Nature Immunology. 18: 1173 |
| Moffett HF, Coon ME, Radtke S, et al. (2017) Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers. Nature Communications. 8: 389 |
| Moffett HF, Cartwright ANR, Kim HJ, et al. (2017) The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection. Nature Immunology |
| Smith TT, Moffett HF, Stephan SB, et al. (2017) Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. The Journal of Clinical Investigation |
| Smith TT, Stephan SB, Moffett HF, et al. (2017) In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers. Nature Nanotechnology |
| Kim HJ, Barnitz RA, Kreslavsky T, et al. (2015) Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science (New York, N.Y.). 350: 334-9 |
| Li S, Moffett HF, Lu J, et al. (2011) MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. Plos One. 6: e16956 |
| Cosmopoulos K, Pegtel M, Hawkins J, et al. (2009) Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. Journal of Virology. 83: 2357-67 |
| Love TM, Moffett HF, Novina CD. (2008) Not miR-ly small RNAs: big potential for microRNAs in therapy. The Journal of Allergy and Clinical Immunology. 121: 309-19 |